Table 1 Demographic, clinical and laboratory data from the 65 included patients
Data | All patients |
|---|---|
Age (SD) | 50.5 (13.4) |
Female (%) | 56 (86.1) |
Afro-Brazilians (%) | 25 (38.4) |
Disease duration years (SD) | 10.6 (7.7) |
Telangiectasia (%) | 29 (44.6) |
Dyspnea | 22 (33%) |
Urate levels (SD) | 4.5 (1.4) |
Left axix deviation | 2 |
FVC % (SD) | 77.8 (16.9) |
DLco % (SD) | 64 (24.1) |
FVC/Dlco (SD) | 1.3 (0.6) |
Detected TRJ (%) | 49 (75) |
mPAP echocardiography mmHg (SD) | 31.9 (14.8) |
ANA nucleolar (%) | 26 (40) |
Antibody positive (%) | 27 (41.5) |
Anti-Scl-70 (%) | 12 (18.4) |
Anti-centromere (%) | 12 (18.4) |